Journey Medical (DERM) Amortizatization of Intangibles (2021 - 2026)
Journey Medical's (DERM) quarterly Amortizatization of Intangibles came in at $96000.0 in Q1 2026, down 4.95% YoY from $101000.0 in Q1 2025, and down 18.64% on a QoQ basis from $118000.0 in Q4 2025.
Journey Medical (DERM) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 6 years of Amortizatization of Intangibles data on file, last reported at $96000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 4.95% year-over-year to $96000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $461000.0 (up 33.24% YoY) and the FY2025 annual result came in at $466000.0, up 51.79% from the prior year.
- Amortizatization of Intangibles declined to $96000.0 in Q1 2026, from $118000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $279000.0 in Q2 2023 to a low of $2000.0 in Q4 2023.
- A 5-year average of $75764.7 and a median of $64000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 99.17% — and 2024, when it soared 4600.0%.
- Tracing DERM's Amortizatization of Intangibles over 5 years: stood at $16000.0 in 2022, then tumbled by 87.5% to $2000.0 in 2023, then soared by 4600.0% to $94000.0 in 2024, then climbed by 25.53% to $118000.0 in 2025, then declined by 18.64% to $96000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $96000.0 (Q1 2026), $118000.0 (Q4 2025), and $123000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Journey Medical | 211.43 Mn | 185.78 Mn | 12.37 Mn | 99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99,000.00 |
| Jun 30, 2026 | 99,000.00 |
| Mar 31, 2026 | 96,000.00 |
| Mar 31, 2026 | 96,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 124,000.00 |
| Jun 30, 2025 | 124,000.00 |
| Mar 31, 2025 | 101,000.00 |
| Mar 31, 2025 | 101,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |